NanoGhost
Targeted Drug Delivery Platform | Home
Netanya, Israel · $9.0M raised
- Headquarters
- Netanya, Center District
- Business Model
- B2B
- Website
- nano-ghost.com
- Total Funding
- $9.0M
- Last Round
- $4.0M Venture RoundAug 2023
- Rounds
- 2
About
NanoGhost develops a first-in-class drug targeting platform using cell membranes of mesenchymal cells for selective tumor and inflammation targeting.
Summary
NanoGhost is a Biotech company based in Netanya, Israel. It has raised $9.0M in total across 2 rounds, most recently a $4.0M Venture Round round in Aug 2023. Investors include aMoon and Mission BioCapital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...